Compounding & Supply News
Every article we’ve published on Compounding & Supply, newest first — 2 in total. Each one is sourced to primary regulatory, trial, or peer-reviewed documents and links back to the original.
Retatrutide Grey Market Tested: Australian Study Checks Labels
A research letter in Drug and Alcohol Review reports laboratory analysis of vials sold under the retatrutide name in Australia — a direct look at what circulates in the retatrutide grey market. It lands while the compound itself is still years from any approval decision, with a 4,500-participant liver outcomes trial now recruiting.
Compounded Glutathione Recall Over Elevated Endotoxin Levels
An Austin, Texas compounding pharmacy has pulled specified lots of an injectable antioxidant preparation after its own testing flagged a contaminant that sterility testing does not catch. The compounded glutathione recall reaches the patient level, which means vials already dispensed to individuals are covered.